| FDC Back to Cashflow Statement | 
FDC Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-92 Cr | ₹-202 Cr | ₹-180 Cr | ₹-9.84 Cr | ₹-129 Cr | 
What is the latest Cash Flow from Financing Activities ratio of FDC ?
| Year | Cash Flow from Financing Activities | 
|---|---|
| Mar2025 | ₹-92 Cr | 
| Mar2024 | ₹-202 Cr | 
| Mar2023 | ₹-180 Cr | 
| Mar2022 | ₹-9.84 Cr | 
| Mar2021 | ₹-129 Cr | 
How is Cash Flow from Financing Activities of FDC Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-92 Cr | Negative | |
| Mar2024 | ₹-202 Cr | Negative | |
| Mar2023 | ₹-180 Cr | Negative | |
| Mar2022 | ₹-9.84 Cr | Negative | |
| Mar2021 | ₹-129 Cr | - | |
Compare Cash Flow from Financing Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,500.2 Cr | 5% | 0.9% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| FDC | 5% | 0.9% | -14.7% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    